CN Patent
CN106074418A — 一种治疗高血压的苯磺酸氨氯地平片及其制备方法
Assigned to Wide Informational Inquiry Centre Of Nanjing China · Expires 2016-11-09 · 10y expired
What this patent protects
本发明涉及一种治疗高血压的苯磺酸氨氯地平片,属于西药制剂技术领域,由以下成分组成:苯磺酸氨氯地平10‑20份,微晶纤维素20‑50份、乳糖30‑70份、L‑酪氨酸10‑20份、预胶化淀粉20‑50份等,采用特定的颗粒搅拌机混合,本发明的片剂缓释平稳。
USPTO Abstract
本发明涉及一种治疗高血压的苯磺酸氨氯地平片,属于西药制剂技术领域,由以下成分组成:苯磺酸氨氯地平10‑20份,微晶纤维素20‑50份、乳糖30‑70份、L‑酪氨酸10‑20份、预胶化淀粉20‑50份等,采用特定的颗粒搅拌机混合,本发明的片剂缓释平稳。
Drugs covered by this patent
- Caduet (Amlodipine Besylate) · Pfizer Inc.
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.